Raia Drogasil S.A. (ADR)
General ticker "RADLY" information:
- Sector: Health Care
- Industry: Medical - Pharmaceuticals
- Capitalization: $5.9B (TTM average)
Raia Drogasil S.A. (ADR) follows the US Stock Market performance with the rate: 20.3%.
Estimated limits based on current volatility of 2.9%: low 4.30$, high 4.56$
Factors to consider:
- Company pays dividends (quarterly): last record date 2025-10-14, amount 0.01$ (Y0.91%)
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.26$, 5.53$]
- 2025-12-31 to 2026-12-31 estimated range: [3.50$, 5.92$]
Financial Metrics affecting the RADLY estimates:
- Positive: with PPE of 26.9 at the end of fiscal year the price was very low
- Positive: -3.60 < Operating profit margin, % of 6.09
- Negative: negative Industry operating cash flow (median)
- Negative: 0.79 < Interest expense per share per price, % of 2.32
- Positive: 18.93 < Shareholder equity ratio, % of 29.03 <= 41.86
- Negative: Industry earnings per price (median), % of -8.66 <= 0
- Positive: Industry inventory ratio change (median), % of -0.48 <= -0.15
Short-term RADLY quotes
Long-term RADLY plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | BRL29,067.38MM | BRL33,973.79MM | BRL38,864.46MM |
| Operating Expenses | BRL27,587.46MM | BRL31,893.30MM | BRL36,497.28MM |
| Operating Income | BRL1,479.92MM | BRL2,080.49MM | BRL2,367.17MM |
| Non-Operating Income | BRL-286.71MM | BRL-863.80MM | BRL-951.46MM |
| Interest Expense | BRL292.69MM | BRL737.79MM | BRL812.72MM |
| Income(Loss) | BRL1,193.21MM | BRL1,216.69MM | BRL1,415.71MM |
| Taxes | BRL178.24MM | BRL129.55MM | BRL206.51MM |
| Profit(Loss)* | BRL996.11MM | BRL1,054.97MM | BRL1,197.69MM |
| Stockholders Equity | BRL5,340.86MM | BRL5,956.00MM | BRL6,428.77MM |
| Inventory | BRL6,126.06MM | BRL7,197.43MM | BRL8,407.43MM |
| Assets | BRL17,185.31MM | BRL20,094.41MM | BRL22,141.69MM |
| Operating Cash Flow | BRL1,682.26MM | BRL962.54MM | BRL1,912.58MM |
| Capital expenditure | BRL1,188.78MM | BRL1,304.58MM | BRL1,283.65MM |
| Investing Cash Flow | BRL-1,229.58MM | BRL-1,307.03MM | BRL-1,412.91MM |
| Financing Cash Flow | BRL-375.25MM | BRL323.27MM | BRL-383.99MM |
| Earnings Per Share** | BRL0.58 | BRL0.62 | BRL0.73 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.